One hundred years of dipyrone (metamizole): the recent evidence on its safety
DOI:
https://doi.org/10.53660/380.prw1407Palavras-chave:
Adverse drug reactions, Agranulocytosis, Non opioid analgesicsResumo
Dipyrone is a non-opioid analgesic drug used for fever and many types of pain. Due to the risk of induced agranulocytosis, it was banned in the early 1980s in several countries, but is still widely used in Brazil, Mexico, China and others. This study is a systematic review of literature focusing on the recent evidence about dipyrone safety. To this, a literature search was performed for epidemiological studies published between 2015 and 2022, in English, German, Portuguese, and Spanish languages. From the 30 articles that met the inclusion criteria, most of them consisted in observational studies (n = 27). In children, the frequency of adverse events with dipyrone is low, but can affect the renal and circulatory systems. During pregnancy, the drug doesn't seem to be related to teratogenic abnormalities. Agranulocytosis is still a matter of debate. However, the occurrence is rare, with an estimated risk of 1:1,602. In adults, dipyrone is related to several adverse effects on renal, hepatic, respiratory and epidermal systems. Thus, dipyrone seems to have a low incidence of adverse effects, but some can be considered of high severity. Especially in children, elderly and patients who need treatment for long periods, other analgesic options should be evaluated.
Downloads
Referências
Kötter T, da Costa BR, Fässler M, Blozik E, Linde K, Jüni P, Reichenbach S, Scherer M. Metamizole-associated adverse events: a systematic review and meta-analysis. PLoS One. 2015 Apr 13;10(4):e0122918. doi: 10.1371/journal.pone.0122918. Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0122918
de Leeuw TG, Dirckx M, Gonzalez Candel A, Scoones GP, Huygen FJPM, de Wildt SN. The use of dipyrone (metamizol) as an analgesic in children: What is the evidence? A review. Paediatr Anaesth. 2017 Dec;27(12):1193-1201. doi: 10.1111/pan.13257. Erratum in: Paediatr Anaesth. 2018 Mar;28(3):309. doi: 10.1111/pan.13257. Available from: https://onlinelibrary.wiley.com/doi/10.1111/pan.13257
Collares EF, Troncon LEA. Effects of dipyrone on the digestive tract. Braz J Med Biol Res. 2019 Jan 10;52(2):e8103. doi: 10.1590/1414-431X20188103. Available from: https://www.scielo.br/j/bjmbr/a/dDkrwGzJnmhrVmdgLhqWG4C
Hearn L, Derry S, Moore RA. Single dose dipyrone (metamizole) for acute postoperative pain in adults. Cochrane Database Syst Rev. 2016 Apr 20;4(4):CD011421. doi: 10.1002/14651858.CD011421.pub2. Available from: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011421.pub2/full
Pires FD, Oliveira VB. Agranulocitose relacionada ao uso de dipirona: uma revisão. Visão Acadêmica. 2015;16(2). doi: 10.5380/acd.v16i2.43023. Available from: https://revistas.ufpr.br/academica/article/view/43023
Malvar DC, Aguiar FA, Vaz ALL, Assis DCR, de Melo MCC, Jabor VAP, Kalapothakis E, Ferreira SH, Clososki GC, de Souza GEP. Dipyrone metabolite 4-MAA induces hypothermia and inhibits PGE2-dependent and -independent fever while 4-AA only blocks PGE2-dependent fever. Br J Pharmacol. 2014 Aug;171(15):3666-79. doi: 10.1111/bph.12717. Available from: https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bph.12717
Rodrigues BTF, Nazaré KA, Fernandes EL, Araújo ME da SA, Saliba WA. Estudo sobre a estabilidade do princípio ativo da dipirona sódica. Brazilian Journal of Surgery and Clinical Research. 2021;36(1):124-129. ISSN online: 2317-4404. Available from: https://www.mastereditora.com.br/periodico/20210906_133233.pdf
Knappmann AL, de Melo EB. Qualidade de medicamentos isentos de prescrição: um estudo com marcas de dipirona comercializadas em uma drogaria de Cascavel (PR, Brasil) [Quality of over-the-counter medicines: a study with dipyrone brands commercialized in a drugstore in Cascavel city (Paraná, Brazil)]. Cien Saude Colet. 2010 Nov;15 Suppl 3:3467-76. Portuguese. doi: 10.1590/s1413-81232010000900021. Available from: https://www.scielo.br/j/csc/a/HNPDvRVPgmszCpNChfK9XDR
Edwards JE, Meseguer F, Faura C, Moore RA, McQuay HJ. Single dose dipyrone for acute renal colic pain. Cochrane Database Syst Rev. 2002;2002(4):CD003867. doi: 10.1002/14651858.CD003867. Available from: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003867/full
Queiroz TP, Santos PL dos, Esteves JC, Stellin GM, Shimizu AS, Junior WB, Vieira EH. Dipirona versus paracetamol no controle da dor pós-operatória. Rev Odontol UNESP. 2013;Mar-Apr;42(2):78-82. Available from: https://www.scielo.br/j/rounesp/a/HTG5ShBM3VyFnThfk65NbPb
Blaser LS, Duthaler U, Bouitbir J, Leuppi-Taegtmeyer AB, Liakoni E, Dolf R, Mayr M, Drewe J, Krähenbühl S, Haschke M. Comparative Effects of Metamizole (Dipyrone) and Naproxen on Renal Function and Prostacyclin Synthesis in Salt-Depleted Healthy Subjects - A Randomized Controlled Parallel Group Study. Front Pharmacol. 2021 Sep 7;12:620635. doi: 10.3389/fphar.2021.620635. Available from: https://www.frontiersin.org/articles/10.3389/fphar.2021.620635/full
Preveden N, Liechti ME, Oettl T, Erb S. Metamizole as a Rare Cause of Drug-Induced Liver Injury. Eur J Case Rep Intern Med. 2022 May 30;9(5):003349. doi: 10.12890/2022_003349. Available from: https://www.ejcrim.com/index.php/EJCRIM/article/view/3349
Bachmann F, Duthaler U, Meyer Zu Schwabedissen HE, Puchkov M, Huwyler J, Haschke M, Krähenbühl S. Metamizole is a Moderate Cytochrome P450 Inducer Via the Constitutive Androstane Receptor and a Weak Inhibitor of CYP1A2. Clin Pharmacol Ther. 2021 Jun;109(6):1505-1516. doi: 10.1002/cpt.2141. Available from: https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.2141
Dathe K, Frank J, Padberg S, Hultzsch S, Beck E, Schaefer C. Fetal adverse effects following NSAID or metamizole exposure in the 2nd and 3rd trimester: an evaluation of the German Embryotox cohort. BMC Pregnancy Childbirth. 2022 Aug 26;22(1):666. doi: 10.1186/s12884-022-04986-4. Available from: https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-022-04986-4
Andrade S, Bartels DB, Lange R, Sandford L, Gurwitz J. Safety of metamizole: a systematic review of the literature. J Clin Pharm Ther. 2016 Oct;41(5):459-77. doi: 10.1111/jcpt.12422. Available from: https://onlinelibrary.wiley.com/doi/10.1111/jcpt.12422
Konijnenbelt-Peters J, van der Heijden C, Ekhart C, Bos J, Bruhn J, Kramers C. Metamizole (Dipyrone) as an Alternative Agent in Postoperative Analgesia in Patients with Contraindications for Nonsteroidal Anti-Inflammatory Drugs. Pain Pract. 2017 Mar;17(3):402-408. doi: 10.1111/papr.12467. Available from: https://onlinelibrary.wiley.com/doi/10.1111/papr.12467
Andrès E, Maloisel F. Idiosyncratic drug-induced agranulocytosis or acute neutropenia. Curr Opin Hematol. 2008 Jan;15(1):15-21. doi: 10.1097/MOH.0b013e3282f15fb9. Available from: https://journals.lww.com/co-hematology/Abstract/2008/01000/Idiosyncratic_drug_induced_agranulocytosis_or.4.aspx
Maytalman E, Samur DN, Gunizi OC, Kozanoglu I. The effects of metamizole on hematopoietic progenitor cells: Suppression of hematopoiesis stimulation in vitro. Bratisl Lek Listy. 2023 Jan 4. doi: 10.4149/BLL_2023_049. Available from: http://www.elis.sk/index.php?page=shop.product_details&flypage=flypage.tpl&product_id=7949&category_id=164&option=com_virtuemart&vmcchk=1&Itemid=1
Arellano F, Sacristán JA Metamizole: reassessment of its therapeutic role. Eur J Clin Pharmacol. 1990;38:617–619. doi: 10.1007/BF00278592. Available from: https://link.springer.com/article/10.1007/BF00278592
Jasiecka A, Maślanka T, Jaroszewski JJ. Pharmacological characteristics of metamizole. Pol J Vet Sci. 2014;17(1):207-14. doi: 10.2478/pjvs-2014-0030. Available from: https://journals.pan.pl/dlibra/publication/114204/edition/99258/content
Stangler MIS, Lubianca JPN, Lubianca JN, Lubianca Neto JF. Dipyrone as pre-emptive measure in postoperative analgesia after tonsillectomy in children: a systematic review. Braz J Otorhinolaryngol. 2021 Mar-Apr;87(2):227-236. doi: 10.1016/j.bjorl.2020.12.005. Available from: https://www.sciencedirect.com/science/article/pii/S1808869420302457
Sümpelmann R, Fieler M, Eich C, Becke K, Badelt G, Leimkühler K, Dennhardt N. Metamizole for Postoperative Pain Therapy in Infants Younger than 1 Year. Eur J Pediatr Surg. 2017 Jun;27(3):269-273. doi: 10.1055/s-0036-1587332. Available from: https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0036-1587332
Fieler M, Eich C, Becke K, Badelt G, Leimkühler K, Messroghli L, Boethig D, Sümpelmann R. Metamizole for postoperative pain therapy in 1177 children: A prospective, multicentre, observational, postauthorisation safety study. Eur J Anaesthesiol. 2015 Dec;32(12):839-43. doi: 10.1097/EJA.0000000000000272. Available from: https://journals.lww.com/ejanaesthesiology/Fulltext/2015/12000/Metamizole_for_postoperative_pain_therapy_in_1177.4.aspx
Zahn J, Eberl S, Rödle W, Rascher W, Neubert A, Toni I. Metamizole Use in Children: Analysis of Drug Utilisation and Adverse Drug Reactions at a German University Hospital between 2015 and 2020. Paediatr Drugs. 2022 Jan;24(1):45-56. doi: 10.1007/s40272-021-00481-z. Available from: https://link.springer.com/article/10.1007/s40272-021-00481-z
Kılıç Ö, İşeri Nepesov M, Ulukapı HB, Özdemir ZC, Bör Ö, Dinleyici EÇ. Paediatric Agranulocytosis Associated with Metamizole Treatment. Paediatr Drugs. 2021 Jan;23(1):105-110. doi: 10.1007/s40272-020-00431-1. Available from: https://link.springer.com/article/10.1007/s40272-020-00431-1
Glanzmann C, Frey B, Vonbach P, Meier CR. Drugs as risk factors of acute kidney injury in critically ill children. Pediatr Nephrol. 2016 Jan;31(1):145-51. doi: 10.1007/s00467-015-3180-9. Available from: https://link.springer.com/article/10.1007/s00467-015-3180-9
Lima EDC, Matos GC, Vieira JML, Gonçalves ICDCR, Cabral LM, Turner MA. Suspected adverse drug reactions reported for Brazilian children: cross-sectional study. J Pediatr (Rio J). 2019 Nov-Dec;95(6):682-688. doi: 10.1016/j.jped.2018.05.019. Available from: https://www.sciencedirect.com/science/article/pii/S0021755718302894
Dathe K, Padberg S, Hultzsch S, Meixner K, Tissen-Diabaté T, Meister R, Beck E, Schaefer C. Metamizole use during first trimester-A prospective observational cohort study on pregnancy outcome. Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1197-1204. doi: 10.1002/pds.4277. Available from: https://onlinelibrary.wiley.com/doi/10.1002/pds.4277
Navarro-Martínez R, Chover-Sierra E, Cauli O. Non-chemotherapy drug-induced agranulocytosis in a tertiary hospital. Hum Exp Toxicol. 2016 Mar;35(3):244-50. doi: 10.1177/0960327115580603. Available from: https://journals.sagepub.com/doi/10.1177/0960327115580603?url_ver=Z39.88-2003&rfr
Klose S, Pflock R, König IR, Linder R, Schwaninger M. Metamizole and the risk of drug-induced agranulocytosis and neutropenia in statutory health insurance data. Naunyn Schmiedebergs Arch Pharmacol. 2020 Apr;393(4):681-690. doi: 10.1007/s00210-019-01774-4. Available from: https://link.springer.com/article/10.1007/s00210-019-01774-4
Stammschulte T, Ludwig WD, Mühlbauer B, Bronder E, Gundert-Remy U. Metamizole (dipyrone)-associated agranulocytosis. An analysis of German spontaneous reports 1990-2012. Eur J Clin Pharmacol. 2015 Sep;71(9):1129-38. doi: 10.1007/s00228-015-1895-y. Available from: https://link.springer.com/article/10.1007/s00228-015-1895-y
Schinz K, Waldfahrer F, Wüst W, Iro H. Agranulozytose nach Metamizol-Einnahme – ein unterschätztes Risiko? [Agranulocytosis after use of metamizole - an underestimated risk?]. Laryngorhinootologie. 2020 Oct;99(10):707-712. German. doi: 10.1055/a-1190-4445. Available from: https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-1190-4445
Hoffmann F, Bantel C, Jobski K. Agranulocytosis attributed to metamizole: An analysis of spontaneous reports in EudraVigilance 1985-2017. Basic Clin Pharmacol Toxicol. 2020; 126:(116–125). Available from: https://onlinelibrary.wiley.com/doi/10.1111/bcpt.13310
Rudin D, Spoendlin J, Cismaru AL, Liakoni E, Bonadies N, Amstutz U, Meier CR, Krähenbühl S, Haschke M. Metamizole-associated neutropenia: Comparison of patients with neutropenia and metamizole-tolerant patients. Eur J Intern Med. 2019 Oct;68:36-43. doi: 10.1016/j.ejim.2019.07.029. Available from: https://www.ejinme.com/article/S0953-6205(19)30264-X/fulltext
Zapater, P., Llanos, L., Barquero, C., Bellot, P., Pascual, S., Carnicer, F., Palazón, J.M., Gimenez, P., Esteban, A., Llorca, L., Francés, R., Horga, J.F. and Such, J. (2015), Acute Effects of Dipyrone on Renal Function in Patients with Cirrhosis: A Randomized Controlled Trial. Basic Clin Pharmacol Toxicol, 116: 257-263. Available from: https://onlinelibrary.wiley.com/doi/10.1111/bcpt.12312
Stueber T, Buessecker L, Leffler A, Gillmann HJ. The use of dipyrone in the ICU is associated with acute kidney injury: A retrospective cohort analysis. Eur J Anaesthesiol. 2017 Oct;34(10):673-680. doi: 10.1097/EJA.0000000000000627. Available from: https://journals.lww.com/ejanaesthesiology/Fulltext/2017/10000/The_use_of_dipyrone_in_the_ICU_is_associated_with.7.aspx
Weber S, Benesic A, Neumann J, Gerbes AL. Liver Injury Associated with Metamizole Exposure: Features of an Underestimated Adverse Event. Drug Saf. 2021 Jun;44(6):669-680. doi: 10.1007/s40264-021-01049-z. Available from: https://link.springer.com/article/10.1007/s40264-021-01049-z
Sebode M, Reike-Kunze M, Weidemann S, Zenouzi R, Hartl J, Peiseler M, Liwinski T, Schulz L, Weiler-Normann C, Sterneck M, Lohse AW, Schramm C. Metamizole: An underrated agent causing severe idiosyncratic drug-induced liver injury. Br J Clin Pharmacol. 2020 Jul;86(7):1406-1415. doi: 10.1111/bcp.14254. Available from: https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bcp.14254
Reike-Kunze M, Zenouzi R, Hartel J, Krech T, Weidemann S, Sterneck M, Weiler-Normann C, Lohse AW, Schramm C, Sebode M. Drug-induced liver injury at a tertiary care centre in Germany: Model for end-stage liver disease is the best predictor of outcome. Liver Int. 2021 Oct;41(10):2383-2395. doi: 10.1111/liv.14985. Available from: https://onlinelibrary.wiley.com/doi/10.1111/liv.14985
Hedenmalm K, Pacurariu A, Slattery J, Kurz X, Candore G, Flynn R. Is There an Increased Risk of Hepatotoxicity with Metamizole? A Comparative Cohort Study in Incident Users. Drug Saf. 2021 Sep;44(9):973-985. doi: 10.1007/s40264-021-01087-7. Available from: https://link.springer.com/article/10.1007/s40264-021-01087-7
Achilles A, Mohring A, Dannenberg L, Piayda K, Levkau B, Hohlfeld T, Zeus T, Kelm M, Polzin A. Analgesic medication with dipyrone in patients with coronary artery disease: Relation to MACCE. Int J Cardiol. 2017 Jun 1;236:76-81. doi: 10.1016/j.ijcard.2017.02.122. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0167-5273(16)34395-9
Polzin A, Dannenberg L, Helten C, Pöhl M, Metzen D, Mourikis P, Dücker C, Marschall U, L'Hoest H, Hennig B, Zako S, Trojovsky K, Petzold T, Jung C, Levkau B, Zeus T, Schrör K, Hohlfeld T, Kelm M. Excess Mortality in Aspirin and Dipyrone (Metamizole) Co-Medicated in Patients With Cardiovascular Disease: A Nationwide Study. J Am Heart Assoc. 2021 Nov 16;10(22):e022299. doi: 10.1161/JAHA.121.022299. Epub 2021 Nov 2. Erratum in: J Am Heart Assoc. 2022 May 3;11(9):e020797. Available from: https://www.ahajournals.org/doi/10.1161/JAHA.121.022299
Agondi RC, Dias GMFS, Assis JP, Pacheco R, Kalil J, Giavina-Bianchi P. Hypersensitivity to dipyrone in aspirin-exacerbated respiratory disease patients is associated with urticaria. Respir Med. 2020 Aug-Sep;170:106041. doi: 10.1016/j.rmed.2020.106041. Available from: https://www.resmedjournal.com/article/S0954-6111(20)30181-5/fulltext
Rodriguez-Martin S, Martin-Merino E, Lerma V, Rodriguez-Miguel A, Gonzalez O, Gonzalez-Herrada C, Ramirez E, Bellon T, de Abajo F.J. Active surveillance of severe cutaneous adverse reactions: A case-population approach using a registry and a health care database. Pharmacoepidemiology and Drug Safety. 2018; 27(9):1042-1050. Available from: https://onlinelibrary.wiley.com/doi/10.1002/pds.4622
González-Cárdenas Victor Hugo, Laverde-Gaona Luis A., Cabarique-Serrano Sergio H., Cháves-Rojas Nataly, Reina-Sierra Jorge A., Infante Juan S. et al . Analysis of the incidence of adverse events related to the administration of dipyrone. Rev. colomb. anestesiol. 2018 June; 46(2):119-125. https://doi.org/10.1097/cj9.0000000000000023. Available from: https://journals.lww.com/rca/Fulltext/2018/06000/Analysis_of_the_incidence_of_adverse_events.6.aspx
Machado-Alba Jorge Enrique, Cardona-Trejos Edwar Andrés, Sánchez Morales Leidy Viviana, Rodríguez-Ramírez Luisa Fernanda. Identificación de reacciones adversas por dipirona en pacientes de un hospital de tercer nivel. CES Med. 2019 Apr; 33(1):13-20. https://doi.org/10.21615/cesmedicina.33.1.2. Available from: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-87052019000100013&lng=en
Blanca-López N, Pérez-Sánchez N, Agúndez JA, García-Martin E, Torres MJ, Cornejo-García JA, Perkins JR, Miranda MA, Andreu I, Mayorga C, Canto G, Blanca M, Doña I. Allergic Reactions to Metamizole: Immediate and Delayed Responses. Int Arch Allergy Immunol. 2016;169(4):223-30. doi: 10.1159/000444798. Available from: https://www.karger.com/Article/FullText/444798#
Cazacu I, Stroe R, Dondera R, Mogosan C, Haramburu F, Fourrier-Réglat A, Loghin F. Adverse drug reactions of analgesic medicines: analysis of the Romanian pharmacovigilance database. Fundam Clin Pharmacol. 2018 June; 32(3):330-336. Available from: https://doi.org/10.1111/fcp.12343. https://onlinelibrary.wiley.com/doi/10.1111/fcp.12343
Demir S, Olgac M, Unal D, Gelincik A, Colakoglu B, Buyukozturk S. Evaluation of hypersensitivity reactions to nonsteroidal anti-inflammatory drugs according to the latest classification. Allergy. 2015 Nov;70(11):1461-7. doi: 10.1111/all.12689. Available from: https://onlinelibrary.wiley.com/doi/10.1111/all.12689
Muñoz LS, López GJ, Orta IA. Characterization of low frequency of onset´s adverse drug reactions. Revista Cubana de Salud Pública. 2018;44(1):71-85. https://www.medigraphic.com/cgi-bin/new/resumenI.cgi?IDARTICULO=80853
Wang C, Fang W, Song L, Deng Z, Li Z, Sun L. Analysis of Clinical Features of Non-steroidal Anti-inflammatory Drugs Induced Kounis Syndrome. Front Cardiovasc Med. 2022 Jul 11;9:901522. doi: 10.3389/fcvm.2022.901522. https://doi.org/10.3389%2Ffcvm.2022.901522. https://www.frontiersin.org/articles/10.3389/fcvm.2022.901522/full
Işik, Melek MD; Kaya, Zuhre MD; Belen, Fatma Burcu MD; Aktaş, Anil Tapisiz MD; Tezer, Hasan MD; Gürsel, Türkiz MD. Life-threatening Agranulocytosis, Anemia, and Plasmacytosis After Dipyrone Use for Fever in a Child. Journal of Pediatric Hematology/Oncology 36(1):p e46-e48, January 2014. | DOI: 10.1097/MPH.0b013e31826e7d9d. Available from: https://journals.lww.com/jpho-online/Abstract/2014/01000/Life_threatening_Agranulocytosis,_Anemia,_and.28.aspx
Aslan N, Yildizdas D, Horoz OO, Ozden O. Fatal Agranulocytosis and Fournier's Gangrene due to the Use of Metamizole. Indian J Pediatr. 2019 Mar;86(3):310-311. doi: 10.1007/s12098-018-2799-5. Available from: https://link.springer.com/article/10.1007/s12098-018-2799-5
Sener M, Kocum A, Caliskan E, Yilmaz I, Caylakli F, Aribogan A. Administration of paracetamol versus dipyrone by intravenous patient-controlled analgesia for postoperative pain relief in children after tonsillectomy. Braz J Anesthesiol. 2015 Nov-Dec;65(6):476-82. doi: 10.1016/j.bjane.2013.09.010. Available from: https://www.sciencedirect.com/science/article/pii/S0104001413001978
Caliskan E, Sener M, Kocum A, Ozyilkan NB, Ezer SS, Aribogan A. The efficacy of intravenous paracetamol versus dipyrone for postoperative analgesia after day-case lower abdominal surgery in children with spinal anesthesia: a prospective randomized double-blind placebo-controlled study. BMC Anesthesiol. 2013 Oct 22;13(1):34. doi: 10.1186/1471-2253-13-34. Available from: https://bmcanesthesiol.biomedcentral.com/articles/10.1186/1471-2253-13-34
da Silva Dal Pizzol T, Schüler-Faccini L, Mengue SS, Fischer MI. Dipyrone use during pregnancy and adverse perinatal events. Arch Gynecol Obstet. 2009 Mar;279(3):293-7. doi: 10.1007/s00404-008-0707-3. Available from: https://link.springer.com/article/10.1007/s00404-008-0707-3
Bánhidy F, Acs N, Puhó E, Czeizel AE. A population-based case-control teratologic study of oral dipyrone treatment during pregnancy. Drug Saf. 2007;30(1):59-70. doi: 10.2165/00002018-200730010-00006. Available from: https://link.springer.com/article/10.2165/00002018-200730010-00006
Bar-Oz B, Clementi M, Di Giantonio E, Greenberg R, Beer M, Merlob P, Arnon J, Ornoy A, Zimmerman DM, Berkovitch M. Metamizol (dipyrone, optalgin) in pregnancy, is it safe? A prospective comparative study. Eur J Obstet Gynecol Reprod Biol. 2005 Apr 1;119(2):176-9. doi: 10.1016/j.ejogrb.2004.07.004. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0301211504003768
Weintraub A, Mankuta D. Dipyrone-induced oligohydramnios and ductus arteriosus restriction. Isr Med Assoc J. 2006 Oct;8(10):722-3. Available from: https://www.ima.org.il/MedicineIMAJ/viewarticle.aspx?year=2006&month=10&page=722
Arruza Gómez L, Corredera Sánchez A, Montalvo Montes J, de Marco Guilarte E, Moro Serrano M. Cierre intrauterino del conducto arterial en probable relación con la ingesta materna de metamizol durante el tercer trimestre de gestación [Intrauterine closure of the ductus arteriosus probably associated with the taking of metamizole during the third trimester]. An Pediatr (Barc). 2008 Jun;68(6):626-7. Spanish. doi: 10.1157/13123300. Available from: https://www.sciencedirect.com/science/article/abs/pii/S1695403308702182
Sánchez de la Nieta MD, Rivera F, De la Torre M, Alcázar R, Caparrós G, Paz Alcaide M, Vozmediano C, Sánchez A. Acute renal failure and oligohydramnios induced by magnesium dypirone (metamizol) in a pregnant woman. Nephrol Dial Transplant. 2003 Aug;18(8):1679-80. doi: 10.1093/ndt/gfg240. Available from: https://academic.oup.com/ndt/article/18/8/1679/1851667
Peces R, Pedrajas A. Non-oliguric acute renal failure and abortion induced by metamizol overdose. Nephrol Dial Transplant. 2004 Oct;19(10):2683-5. doi: 10.1093/ndt/gfh372. Available form: https://academic.oup.com/ndt/article/19/10/2683/1925614
Rattay B, Benndorf RA. Drug-Induced Idiosyncratic Agranulocytosis - Infrequent but Dangerous. Front Pharmacol. 2021 Aug 13;12:727717. doi: 10.3389/fphar.2021.727717. Available from: https://www.frontiersin.org/articles/10.3389/fphar.2021.727717/full
Hedenmalm K, Spigset O. Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole). Eur J Clin Pharmacol. 2002 Jul;58(4):265-74. doi: 10.1007/s00228-002-0465-2. Available from: https://link.springer.com/article/10.1007/s00228-002-0465-2
Dina DN, Eriksson KK, Rudin D, Haschke M, Yerly D. Involvement of the adaptive immune system in metamizole-induced agranulocytosis. Clinical and Translational Allergy 2018;8(Suppl 3):P117. doi: 10.1186/s13601-018-0217-8. Available from: https://onlinelibrary.wiley.com/doi/10.1186/s13601-018-0217-8
Rudin D, Haschke M, Krahenbuhl S. Mechanisms of cytotoxicity involved in metamizole-induced neutropenia. Clinical Toxicology. 2017;55(5): 498-499. doi: 10.1080/15563650.2017.1309792. Available from: https://www.tandfonline.com/doi/abs/10.1080/15563650.2017.1309792
Rudin D, Krahenbuhl S, Haschke M. Susceptibility to the metamizole metabolite N-methyl-4- aminoantipyrine (MAA) depends on the differentiation state of myeloid progenitor cells. Clinical Toxicology. 2019;57(6):485. doi: Clinical Toxicology 2019 57:6 (485). Available from: https://www.eapcct.org/publicfile.php?folder=congress&file=Abstracts_Naples.pdf
Lucas GNC, Leitão ACC, Alencar RL, Xavier RMF, Daher EF, Silva Junior GBD. Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs. J Bras Nefrol. 2019 Jan-Mar;41(1):124-130. doi: 10.1590/2175-8239-JBN-2018-0107. Available from: https://www.scielo.br/j/jbn/a/MbxwF9ZHqk4rfcK3VN7N6Nz/
Rodríguez Ourens MJ, Morales Martínez A. ¿Tenemos en cuenta al prescribir antiinflamatorios no esteroideos su nefrotoxicidad? Fracaso renal agudo en varón de 23 años [Do we care the nephrotoxicity consequences of prescribing NSAID'S? Acute renal failure in 23 year old male]. Semergen. 2017 Mar;43(2):156-158. Spanish. doi: 10.1016/j.semerg.2016.06.003. Available from: https://www.sciencedirect.com/science/article/abs/pii/S113835931630096X
Pohl J, Bischoff P, Oellinger R, Schoening W, Lurje G, Pratschke J, Horst D, Tacke F, Wree A. Liver Transplantation for Metamizole induced Acute Liver Failure. Transplant Proc. 2022 Sep;54(7):1854-1858. doi: 10.1016/j.transproceed.2022.04.028. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0041134522004225
Polzin A, Zeus T, Schrör K, Kelm M, Hohlfeld T. Dipyrone (metamizole) can nullify the antiplatelet effect of aspirin in patients with coronary artery disease. J Am Coll Cardiol. 2013 Oct 29;62(18):1725-1726. doi: 10.1016/j.jacc.2013.07.039. Available from: https://www.sciencedirect.com/science/article/pii/S073510971302946X
Gulmez SE, Celik G, Misirligil Z, Tulunay FC. Dipyrone improves small airway function in asthmatic patients with moderate obstruction. J Investig Allergol Clin Immunol. 2007;17(4):242-8. Available from: http://www.jiaci.org/issues/vol17issue04/vol17issue04-6.htm
Gulmez SE, Tulunay FC, Beder S, Kayacan O, Karnak D. Does dipyrone have any effect on respiratory function in COPD patients? Respir Med. 2006 May;100(5):828-34. doi: 10.1016/j.rmed.2005.09.002. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0954611105003483
Franca MD, Lima JP, Freitas Dd, Cunha M, Gomes JA. Estudo dos achados oculares na síndrome de Stevens-Johnson em pacientes de centro de referência de atendimento terciário [Study of the ocular findings in Stevens-Johnson syndrome patients from a tertiary ophthalmologic center]. Arq Bras Oftalmol. 2009 May-Jun;72(3):370-4. Portuguese. doi: 10.1590/s0004-27492009000300017. Available from: https://www.scielo.br/j/abo/a/HqXS6mCpw9xvPWcvb8Fd3Lr/
Rodríguez-Martín S, Martín-Merino E, Lerma V, Rodríguez-Miguel A, González O, González-Herrada C, Ramírez E, Bellón T, de Abajo FJ. Incidence of Stevens-Johnson syndrome/toxic epidermal necrolysis among new users of different individual drugs in a European population: a case-population study. Eur J Clin Pharmacol. 2019 Feb;75(2):237-246. doi: 10.1007/s00228-018-2569-3. Available from: https://link.springer.com/article/10.1007/s00228-018-2569-3
Abreu S, Castelblanco-Arango IY, Gómez-Pineda PA, Cardona R. Provocación farmacológica para identificar alternativas analgésicas en infante con síndrome de Stevens-Johnson por ibuprofeno-acetaminofén. Rev Alerg Mex . 2020;67(2):189-95. doi: 10.29262/ram.v67i2.712. Available from: https://www.scielo.org.mx/pdf/ram/v67n2/2448-9190-ram-67-02-189.pdf
Mota DM, Vigo Á, Kuchenbecker R de S. Reações adversas a medicamentos no sistema de farmacovigilância do Brasil, 2008 a 2013: estudo descritivo. Cad Saúde Pública [Internet]. 2019;35(Cad. Saúde Pública, 2019 35(8)):e00148818. Available from: https://doi.org/10.1590/0102-311X00148818
Santana SPD, Gonçalves KAM. Reações adversas a medicamentos: um problema de saúde pública / Adverse drug reactions: a public health problem. Braz. J. Hea. Rev. [Internet]. 2021 Dec. 27;4(6):28899-915. Available from: https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/41872
Machado-Alba JE, Urbano-Garzón SF, Gallo-Gómez YN, Zuluaica S, Henao YK, Parrado-Fajardo IY. Severe anaphylaxis reaction from dipyrone without a history of hypersensitivity. Case report. Colombian Journal of Anesthesiology. 2017;45:8-11. Doi: https://doi.org/10.1016/J.RCAE.2015.11.011
